Leerink Partners was bookrunner; Wells Fargo, JMP Securities assisted
By Devika Patel
Knoxville, Tenn., Aug. 23 – OncoMed Pharmaceuticals, Inc. said the underwriters for its public offering of stock opted to exercise the deal’s $8.25 million greenshoe in full, lifting total proceeds of the offering to $63.25 million. The deal was announced Aug. 17 and priced for $55 million with the greenshoe on Aug. 18.
The company sold 6,325,000 common shares at $10.00 apiece. The price per share is a 14.6% discount to the Aug. 17 closing share price of $11.71. Of the shares, 825,000 were part of the fully exercised greenshoe.
Leerink Partners LLC was the bookrunner.
Proceeds will be used for general corporate purposes.
The biopharmaceutical company is based in Redwood City, Calif.
| Issuer: | OncoMed Pharmaceuticals, Inc.
|
| Issue: | Common shares
|
| Amount: | $63.25 million, including $8.25 million greenshoe of 825,000 shares
|
| Shares: | 6,325,000
|
| Price: | $10.00
|
| Warrants: | No
|
| Bookrunners: | Leerink Partners LLC
|
| Co-managers: | Wells Fargo Securities, LLC and JMP Securities LLC
|
| Announcement date: | Aug. 17
|
| Pricing date: | Aug. 18
|
| Settlement date: | Aug. 23
|
| Stock symbol: | Nasdaq: OMED
|
| Stock price: | $11.71 at close Aug. 17
|
| Market capitalization: | $397.17 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
